Comparison between Akums Drugs IPO and Unicommerce eSolutions IPO.
Akums Drugs IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Unicommerce eSolutions IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Akums Drugs IPO is up to ₹1,856.74 Cr whereas the issue size of the Unicommerce eSolutions IPO is up to ₹276.57 Cr. The final issue price of Akums Drugs IPO is ₹679.00 per share and of Unicommerce eSolutions IPO is ₹108.00 per share.
| Akums Drugs IPO | Unicommerce eSolutions IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹1 per share |
| Issue Price (Lower) | ₹646.00 per share | ₹102.00 per share |
| Issue Price (Upper) | ₹679.00 per share | ₹108.00 per share |
| Issue Price (Final) | ₹679.00 per share | ₹108.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹64.00 per share | |
| Market Lot Size | 22 shares | 138 shares |
| Fresh Issue Size | 1,00,37,708 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹680.99 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 1,73,30,435 shares | 2,56,08,512 shares |
| OFS Issue Size (Amount) | up to ₹1,175.75 Cr | up to ₹276.57 Cr |
| Issue Size Total | 2,73,68,143 shares | 2,56,08,512 shares |
| Issue Size Total (Amount) | up to ₹1,856.74 Cr | up to ₹276.57 Cr |
Akums Drugs IPO opens on Jul 30, 2024, while Unicommerce eSolutions IPO opens on Aug 06, 2024. The closing date of Akums Drugs IPO and Unicommerce eSolutions IPO is Aug 01, 2024, and Aug 08, 2024, respectively.
| Akums Drugs IPO | Unicommerce eSolutions IPO | |
|---|---|---|
| Anchor Bid Date | Jul 29, 2024 | Aug 05, 2024 |
| Issue Open | Jul 30, 2024 | Aug 06, 2024 |
| Issue Close | Aug 01, 2024 | Aug 08, 2024 |
| Basis Of Allotment (Tentative) | Aug 02, 2024 | Aug 09, 2024 |
| Initiation of Refunds (Tentative) | Aug 05, 2024 | Aug 12, 2024 |
| Credit of Share (Tentative) | Aug 05, 2024 | Aug 12, 2024 |
| Listing date (Tentative) | Aug 06, 2024 | Aug 13, 2024 |
| Anchor Lockin End date 1 | Sep 01, 2024 | Sep 07, 2024 |
| Anchor Lockin End date 2 | Oct 31, 2024 | Nov 06, 2024 |
Akums Drugs IPO P/E ratio is , as compared to Unicommerce eSolutions IPO P/E ratio of 84.59.
| Akums Drugs IPO | Unicommerce eSolutions IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 82.48 | 48.63 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 75.29 | 39.42 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 84.59 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹1106.29 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 0.11% | 17.36% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 3.37% | 25.93% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.69 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹1.28 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -0.57 | 18.98% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Akums Drugs IPO Retail Individual Investors (RII) are offered 27,12,424 shares while in Unicommerce eSolutions IPO retail investors are offered 27,12,424 shares. Qualified Institutional Buyers (QIB) are offered 81,37,276 shares in Akums Drugs IPO and 76,82,554 shares in Unicommerce eSolutions IPO.
| Akums Drugs IPO | Unicommerce eSolutions IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,22,05,912 shares | 1,15,23,831 shares |
| Market Maker Reservation | ||
| QIB | 81,37,276 shares | 76,82,554 shares |
| NII | 40,68,637 shares | 38,41,276 shares |
| RII | 27,12,424 shares | 25,60,851 shares |
| Employee | 2,43,902 shares | |
| Others | ||
| Total | 2,73,68,151 shares | 2,56,08,512 shares |
Akums Drugs IPO subscribed 63.44x in total, whereas Unicommerce eSolutions IPO subscribed 168.35x.
| Akums Drugs IPO | Unicommerce eSolutions IPO | |
|---|---|---|
| QIB (times) | 90.09x | 138.75x |
| NII (times) | 42.10x | 252.46x |
| Big NII (times) | 47.43x | 266.49x |
| Small NII (times) | 31.45x | 224.38x |
| RII (times) | 20.80x | 130.99x |
| Employee (times) | 4.14x | |
| Other (times) | ||
| Total (times) | 63.44x | 168.35x |
